Advance in Targeted Cancer Therapy and Mechanisms of Resistance

被引：0
|
作者：
Tang, Patrick Ming-Kuen [1 ]
Zhang, Dongmei [2 ]
机构：
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Translat Oncol, Hong Kong, Peoples R China
[2] Jinan Univ, Coll Pharm, Guangzhou 510632, Peoples R China
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 23期
关键词：
D O I：
10.3390/ijms242316584
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer
    Zhang, Rui
    Su, Chang
    Jia, Yongliang
    Xing, Menglu
    Jin, Shuiling
    Zong, Hong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [42] Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
    Chhouri, Houssein
    Alexandre, David
    Grumolato, Luca
    CANCERS, 2023, 15 (02)
  • [43] Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR-mutated lung cancer
    Treue, Denise
    Bockmayr, Michael
    Stenzinger, Albrecht
    Heim, Daniel
    Hester, Svenja
    Klauschen, Frederick
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (03) : 545 - 557
  • [44] Inhibition of hedgehog signaling by cyclopamine prodrug: Targeted therapy for advance prostate cancer
    Khan, S. R.
    Kumar, S.
    Gong, R.
    Miatra, A.
    Beachy, P.
    EJC SUPPLEMENTS, 2006, 4 (12): : 161 - 161
  • [45] Overcoming resistance to antibody targeted therapy in ovarian cancer
    Urbanska, Katarzyna
    Poussin, Mathilde
    Stashwick, Caitlin
    Smith, Jenessa B.
    Powell, Daniel J., Jr.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [46] At the crossroads of cancer stem cells and targeted therapy resistance
    Wang, Anbang
    Qu, Le
    Wang, Linhui
    CANCER LETTERS, 2017, 385 : 87 - 96
  • [47] The influence of subclonal resistance mutations on targeted cancer therapy
    Schmitt, Michael W.
    Loeb, Lawrence A.
    Salk, Jesse J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (06) : 335 - 347
  • [48] Resistance to ErbB targeted therapy in breast cancer.
    Bacus, SS
    Hortobagyi, G
    Spector, N
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9113S - 9113S
  • [49] Adaptive stress signaling in targeted cancer therapy resistance
    E Pazarentzos
    T G Bivona
    Oncogene, 2015, 34 : 5599 - 5606
  • [50] Adaptive stress signaling in targeted cancer therapy resistance
    Pazarentzos, E.
    Bivona, T. G.
    ONCOGENE, 2015, 34 (45) : 5599 - 5606
12345